FORDYCE MARSHALL (President and CEO) sold 7.3% of their position (18.50K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $684.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2026ACC: 0001859453-26-000015
DirectorOfficer· President and CEO
Since May 2021
-18.50K
Net shares
Net seller
$684.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.50K acquired · 37K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+18.50K
Price / share
$2.90
Trade value
$53.59K
% of position
7.9%
9/15/2026
235.24K→253.74K
Class A Common Stock
Direct
Shares
−18.50K
Price / share
$37.00
Trade value
$684.50K
% of position
7.3%
9/15/2026
253.74K→235.24K
Total
Net shares
+0.00
Net value
-$630.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/15/2026 | M · Option Exercise | +18.50K | $2.90 | $53.59K | 7.9% | 235.24K | 253.74K |
| Class A Common Stock Direct | 9/15/2026 | S · Sale | −18.50K | $37.00 | $684.50K | 7.3% | 253.74K | 235.24K |
| Total | +0.00 | -$630.91K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
18.50K shares
Shares
−18.50K
Strike price
2.8968
Held after
488.80K
Exercisable
—
9/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock18.50K shares | 9/15/2026 | M · Option Exercise | −18.50K | 2.8968 | — | 488.80K |